All In Biotech

Free tool

FAERS Monitor: Revlimid

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021880 or its brand name (Revlimid, Lenalidomide). Reports on generic versions are filed under their own applications.

Reports

425,916

Serious

271,846

64% of reports

Hospitalization

110,525

Death reported

54,138

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea31,968
  • fatigue27,107
  • death26,885
  • off label use19,177
  • pneumonia19,040
  • rash18,551
  • plasma cell myeloma17,292
  • neuropathy peripheral12,297
  • white blood cell count decreased12,018
  • constipation11,201
  • nausea10,998
  • asthenia10,240
  • product dose omission issue10,080
  • platelet count decreased9,655
  • neutropenia9,518

Reports by year received

View as table
YearReports
200515
2006820
20071,497
20083,609
20092,897
20103,897
20116,340
201211,712
201310,519
20149,108
201534,550
201625,534
201728,602
201826,535
201930,129
202033,935
202152,556
202243,269
202329,356
202430,439
202523,903
202616,693

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,628,243 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
plasma cell myelomaSignal17,29238.537.7352,422
neuropathy peripheralSignal12,2977.27.057,240
white blood cell count decreasedSignal12,0186.05.945,094
platelet count decreasedSignal9,6554.84.726,708
neutropeniaSignal9,5183.63.617,071
pneumoniaSignal19,0403.03.024,639
constipationSignal11,2012.62.610,748
diarrhoeaSignal31,9682.52.528,763
rashSignal18,5512.22.111,164
fatigue27,1071.71.78,646
product dose omission issue10,0801.71.72,957
death26,8851.61.55,435
asthenia10,2401.41.3941
off label use19,1771.11.1125
nausea10,9980.70.71,673

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.